Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50040140
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389761(CHEMBL2070098)
Affinity DataIC50: 100nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389760(CHEMBL2070097)
Affinity DataIC50: 190nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389753(CHEMBL2070095)
Affinity DataIC50: 300nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389760(CHEMBL2070097)
Affinity DataIC50: 310nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389767(CHEMBL2070236)
Affinity DataIC50: 430nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389752(CHEMBL2070096)
Affinity DataIC50: 460nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389761(CHEMBL2070098)
Affinity DataIC50: 660nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389751(CHEMBL2070238)
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389754(CHEMBL2070094)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389765(CHEMBL2070234)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389755(CHEMBL2070093)
Affinity DataIC50: 1.10E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389762(CHEMBL2070099)
Affinity DataIC50: 1.30E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389763(CHEMBL2070232)
Affinity DataIC50: 1.40E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389763(CHEMBL2070232)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389764(CHEMBL2070233)
Affinity DataIC50: 1.60E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389765(CHEMBL2070234)
Affinity DataIC50: 1.70E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389766(CHEMBL2070235)
Affinity DataIC50: 1.80E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389767(CHEMBL2070236)
Affinity DataIC50: 2.10E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389762(CHEMBL2070099)
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389768(CHEMBL2070237)
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389768(CHEMBL2070237)
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389766(CHEMBL2070235)
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389764(CHEMBL2070233)
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389751(CHEMBL2070238)
Affinity DataIC50: 2.80E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389759(CHEMBL2070239)
Affinity DataIC50: 3.20E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389752(CHEMBL2070096)
Affinity DataIC50: 3.30E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389753(CHEMBL2070095)
Affinity DataIC50: 3.40E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389756(CHEMBL2070092)
Affinity DataIC50: 3.50E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM70858([2-(1-adamantylamino)-2-oxoethyl] 4-methylsulfonyl...)
Affinity DataIC50: 4.10E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389754(CHEMBL2070094)
Affinity DataIC50: 4.20E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389758(CHEMBL2070090)
Affinity DataIC50: 4.70E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389755(CHEMBL2070093)
Affinity DataIC50: 5.20E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor alpha(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389757(CHEMBL2070091)
Affinity DataIC50: 5.60E+3nMAssay Description:Antagonist activity at human TRalpha assessed as inhibition of interaction with SRC2-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389756(CHEMBL2070092)
Affinity DataIC50: 7.10E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389757(CHEMBL2070091)
Affinity DataIC50: 7.40E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389758(CHEMBL2070090)
Affinity DataIC50: 8.20E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetThyroid hormone receptor beta(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389759(CHEMBL2070239)
Affinity DataIC50: 8.50E+3nMAssay Description:Antagonist activity at human TRbeta assessed as inhibition of interaction with SRC2-2 after 3 hrs by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389759(CHEMBL2070239)
Affinity DataIC50: 3.02E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389753(CHEMBL2070095)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389754(CHEMBL2070094)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389755(CHEMBL2070093)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389751(CHEMBL2070238)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389756(CHEMBL2070092)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389757(CHEMBL2070091)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389758(CHEMBL2070090)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389760(CHEMBL2070097)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389762(CHEMBL2070099)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389761(CHEMBL2070098)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389752(CHEMBL2070096)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
TargetPeroxisome proliferator-activated receptor gamma(Human)
Institut Pasteur Korea

Curated by ChEMBL
LigandPNGBDBM50389768(CHEMBL2070237)
Affinity DataIC50: 6.00E+4nMAssay Description:Antagonist activity at human PPAR-gamma assessed as inhibition of interaction with DRIP-2 by fluorescence polarisation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/8/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: